Immutep Limited
PRRUF
$0.04
-$0.01-21.86%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 692.57% | 706.30% | 92.84% | 86.96% | 5.96% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 688.79% | 702.37% | 92.84% | 86.96% | 6.47% |
| Cost of Revenue | 35.09% | 37.42% | 85.39% | 79.72% | 66.14% |
| Gross Profit | 1.17% | -0.54% | -84.33% | -78.69% | -71.47% |
| SG&A Expenses | 1.17% | 2.91% | 29.17% | 25.23% | 5.86% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 31.39% | 33.66% | 77.34% | 71.92% | 56.44% |
| Operating Income | 0.90% | -0.81% | -75.49% | -70.13% | -60.13% |
| Income Before Tax | 5.16% | 3.53% | -101.92% | -95.75% | -76.69% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 5.16% | 3.53% | -101.92% | -95.75% | -76.69% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.16% | 3.53% | -101.92% | -95.75% | -76.69% |
| EBIT | 0.90% | -0.81% | -75.49% | -70.13% | -60.13% |
| EBITDA | 1.03% | -0.68% | -78.15% | -72.71% | -62.54% |
| EPS Basic | 5.81% | 4.76% | -100.00% | -92.31% | -48.28% |
| Normalized Basic EPS | 7.41% | 3.85% | -103.23% | -93.75% | -50.00% |
| EPS Diluted | 5.81% | 4.76% | -100.00% | -92.31% | -48.28% |
| Normalized Diluted EPS | 7.41% | 3.85% | -103.23% | -93.75% | -50.00% |
| Average Basic Shares Outstanding | 0.95% | 0.95% | 1.22% | 1.22% | 19.93% |
| Average Diluted Shares Outstanding | 0.95% | 0.95% | 1.22% | 1.22% | 19.93% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |